Matteo Lambertini

Matteo Lambertini has conducted pivotal meta-analyses demonstrating that GnRH agonist co-administration during chemotherapy significantly reduces premature ovarian insufficiency and improves post-treatment fertility outcomes in premenopausal breast cancer patients. His work on international fertility preservation guidelines has standardized the recommendations for oncofertility counseling and intervention across cancer types. His research on pregnancy outcomes after cancer treatment has built the evidence base showing that pregnancy does not adversely affect cancer prognosis in breast and other hormone-sensitive cancers.